Engineered aryl sulfate-dependent enzymes
AssigneeOptimvia, LLC
InventorTarsis Gesteira Ferreira
Life of this patent
Estimating the term…
Loading patent…
AssigneeOptimvia, LLC
InventorTarsis Gesteira Ferreira
Estimating the term…
The present invention provides several non-naturally occurring sulfotransferase enzymes that have been engineered to react with aryl sulfate compounds as sulfo group donors, instead of the natural substrate 3′-phosphoadenosine 5′-phosphosulfate (PAPS), and with heparosan-based polysaccharides, particularly heparan sulfate, as sulfo group acceptors. Each of the engineered sulfotransferase enzymes have a biological activity characterized by the position within the heparosan-based polysaccharide that receives the sulfo group, including glucosaminyl N-sulfotransferase activity, hexuronyl 2-O sulfotransferase activity, glucosaminyl 6-O sulfotransferase activity, or glucosaminyl 3-O sulfotransferase activity. Methods of using the engineered sulfotransferases to produce sulfated heparosan-based polysaccharides, including polysaccharides having anticoagulant activity, are also provided.
A method of enzymatically forming an N-sulfated heparosan product in the absence of 3′-phosphoadenosine 5′-phosphosulfate (PAPS), the method comprising the following steps:
A non-natural N-sulfotransferase enzyme (NST) enzyme engineered to have sulfotransferase activity with an aryl sulfate compound as a sulfo group donor and N-deacetylated heparosan as a sulfo group acceptor in the absence of 3′-phosphoadenosine 5′-phosphosulfate (PAPS), wherein the NST enzyme comprises an amino acid sequence selected from the group consisting of SEQ ID NO:
Dependencies are inferred from the claim text.